Jnj sotck.

With an average target price of $178.79, analysts give JNJ stock implied upside of about 10% in the next 12 months or so. Add in the dividend yield, and the implied total return comes to roughly 13%.Johnson & Johnson: An Exploration into Its Intrinsic Value Nov 27 / GuruFocus News - Paid Partner Content Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on ItJohnson & Johnson (JNJ) stock forecast and price target. Find the latest Johnson & Johnson JNJ analyst stock forecast, price target, and recommendation trends with in-depth analysis from research ...Developing products for healthier people and planet. Innovating to create formulations that have the power to change the world while protecting the planet. Everyday care is a powerful catalyst in making you feel better, inside and out. Learn about the iconic brands, products, people, and history that make up Kenvue.Johnson & Johnson analyst ratings, historical stock prices, ... Stock Price Target JNJ. High $ 215.00: Median $ 172.00: Low $ 155.00: Average $ 175.42: Current Price $ 154.66: Related Links: Options;

Johnson & Johnson share price live 152.15, this page displays NYSE JNJ stock exchange data. View the JNJ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Johnson & Johnson real time stock price chart below. You can find more ...Right now, analysts are expecting 2023 S&P 500 EPS to be $225 per share followed by $250 EPS in 2024, which is a robust 11.1% year over year growth rate. …Aug 15, 2023 · The exchange offer provides a boon to J&J ( JNJ) shareholders as they would get Kenvue ( KVUE) stock at around a 7% discount. These shareholders would get $107.53 of Kenvue ( KVUE) common stock ...

6 hours ago · That being said, as with JNJ, PG stock is not particularly attractively priced at the moment with a 23.3x P/E ratio (against a historical average of 20x) and a 2.5% dividend yield (against a ... Johnson & Johnson Stock Skirts a 52-Week Low. Here’s What’s Ailing Healthcare. By Josh Nathan-Kazis. Oct 24, 2023, 2:14 pm EDT. Share. Resize. Reprints.

Why Trade JNJ with AvaTrade · Award-winning and reputable broker with international regulation in various jurisdictions · Short sell the JNJ stock · Access ...J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.Jul 24, 2023 · The exchange offer will permit Johnson & Johnson shareholders to exchange some, all or none of their shares of Johnson & Johnson common stock for shares of Kenvue common stock at a 7% discount, subject to an upper limit of 8.0549 shares of Kenvue common stock per share of Johnson & Johnson common stock tendered and accepted in the exchange offer. MedTech. Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases.

Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

Johnson & Johnson has increased its dividend for the past 61 consecutive years. When did Johnson & Johnson last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.06 on Tuesday, April 18, 2023.

Get Johnson & Johnson JNJ price, chart, market capitalization and other stock info about Johnson & Johnson. Open this page to get detailed information about ...Currently, Johnson & Johnson’s price-earnings ratio is 32.2. Johnson & Johnson’s trailing 12-month revenue is $87.5 billion with a 35.5% profit margin. Year-over-year quarterly sales growth most recently was 6.8%. Analysts expect adjusted earnings to reach $10.056 per share for the current fiscal year.Dec 1, 2023 · Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Oct 14, 2023 · Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ... Nov 12, 2021 · The initial reaction of the markets was positive. As of 11:50 a.m. Eastern Standard Time on Nov. 12, 2021, the date of the announcement, shares of JNJ were up by about 1.3% for the day. 6 hours ago · That being said, as with JNJ, PG stock is not particularly attractively priced at the moment with a 23.3x P/E ratio (against a historical average of 20x) and a 2.5% dividend yield (against a ... JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...Johnson & Johnson Stock Earnings. The value each JNJ share was expected to gain vs. the value that each JNJ share actually gained. JNJ ( JNJ) reported Q3 2023 earnings per share (EPS) of $1.98, missing estimates of $2.52 by 21.38%. In the same quarter last year, JNJ 's earnings per share (EPS) was $1.68. JNJ is expected to release next earnings ...LMT | Complete Lockheed Martin Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stocks in Toronto were on the move upward Thursday to conclude a noteworthy November, led primarily ... Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.Looking more closely at the company’s 10-Q, it looks like Berkshire raised $7.0 billion from stock sales during the third quarter—some of which may have been fueled by ongoing sales of BYD.Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed ...

Mar 2, 2023 · For the current quarter, Johnson & Johnson is expected to post earnings of $2.51 per share, indicating a change of -6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% ... New Brunswick, N.J. (April 19, 2022) – Johnson & Johnson today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per share to $1.13 per share. “In recognition of our 2021 results, strong financial position, and confidence in the future of Johnson & Johnson, the Board of Directors has ...

Stock Split Information table; Record Date Pay Out Date Action; May 22, 2001: June 12, 2001: 2 for 1 Split: May 21, 1996: June 11, 1996: 2 for 1 Split: May 19, 1992JNJ Stock Forecast. For 2021, analysts expect JNJ to earn $9.55 per share, and for 2022, analysts expect $10.42 in earnings. JNJ trades for a little under $170 as of my writing this, so your ...Dec 1, 2023 · Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.14%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%. JNJ: Johnson & Johnson - Stock Price, Quote and News - CNBCJohnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Mar 1, 2023 · Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment. Analyst Forecast. According to 15 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $169.07, which is an increase of ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of ...

JNJ Stock Performances on October 12, 2023. On October 12, 2023, JNJ stock had a mixed performance, with some positive and negative indicators. Starting with the previous day’s close, JNJ stock closed at $156.18. The following day, the stock opened slightly lower at $155.89. Throughout the day, the stock had a range of $155.27 to $156.55.View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Johnson & Johnson (JNJ) Company Description: Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices.Separation enhances Company focus on Pharmaceutical and MedTech Research & Development to deliver innovative and differentiated health outcomes Johnson & Johnson shareholders can exchange all, some or none of their shares of Johnson & Johnson common stock for shares of Kenvue Provides Johnson & Johnson …Johnson & Johnson stock has received a consensus rating of buy. The average rating score is Aaa and is based on 36 buy ratings, 34 hold ratings, and 1 sell ratings. What was the 52-week low for ...Earnings for Johnson & Johnson are expected to grow by 6.71% in the coming year, from $10.13 to $10.81 per share. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 23rd, 2024 based off prior year's report dates. Read More.Johnson & Johnson (JNJ 0.72%) stock had a bit of a hangover Wednesday. Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%.Fundamentals. Return on Equity. 17.70%. Trailing 12-Months. Asset Growth. -5.18%. Trailing 12-Months. The Johnson & Johnson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors.9 Okt 2023 ... ... stock. On the medtech side, the analysts identified J&J's leadership position in 11 categories, shift to fast-growing markets, investment in ...Johnson & Johnson JNJ provided an updated financial guidance for 2023, ... which began trading on the New York Stock Exchange with effect from May 4. J&J owned 89.6% of total outstanding shares of ...Oct 14, 2023 · Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ... Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ...Week of November 27, 2023 ... NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends ...Johnson & Johnson Common Stock (JNJ) Stock Price, Quote, News & History | Nasdaq MY QUOTES: JNJ Edit my quotes Johnson & Johnson Common Stock (JNJ) 0 Add to …Discover historical prices for JBLU stock on Yahoo Finance. View daily, weekly or monthly format back to when JetBlue Airways Corporation stock was issued.Instagram:https://instagram. etf for us dollarbest stocks to sell covered calls 2023spg'shigh end jewelry insurance Find the latest VBI Vaccines Inc. (VBIV) stock quote, history, news and other vital information to help you with your stock trading and investing. how to know if your quarter is worth moneythimble insurance review Johnson & Johnson historical stock charts and prices, analyst ratings, financials, and today’s real-time JNJ stock price. ... Johnson & Johnson JNJ (U.S.: NYSE) search. … stock portfolio tracking If prices of JNJ and KVUE don't change dramatically in the next two weeks, the 7.5% incentive premium to tender will allow shareholders to own the stock around the IPO price of $22. KVUE closed ...Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ...The exchange offer will permit Johnson & Johnson shareholders to exchange some, all or none of their shares of Johnson & Johnson common stock for shares of Kenvue common stock at a 7% discount, subject to an upper limit of 8.0549 shares of Kenvue common stock per share of Johnson & Johnson common stock tendered and accepted in the exchange offer.